GLP-1 drug costs represented an average of 10.5% of total annual insurance claims in 2024, up from 8.9% in 2023 and 6.9% in 2022, IFEBP found
For patients using currently available injectable GLP-1 medications , common errors include injecting into the same site repeatedly, failing to allow refrigerated medication to reach room temperature before injection, not rotating injection sites properly, and incorrect pen device technique
Maik Wiedenbach is a Hall of Fame swimmer turned bodybuilding champion and fitness model featured in Muscle & Fitness and Mens Journal
Be Active Regular physical activity supports metabolism and long-term weight management
Appetite Control Retatrutide controls appetite by helping people feel full with less food
Frequently Asked Questions About GLP-3 (Reta) What is GLP-3 (Reta) used for in research?+ What purity is Koi's GLP-3 (Reta)?+ How do I reconstitute GLP-3 (Reta)?+ What is the CAS number for GLP-3 (Reta)?+ How does GLP-3 (Reta) compare with GLP-1 (Sema) and GLP-2 (Triz) as a research tool?+ Is GLP-3 (Reta) FDA-approved?+ How should GLP-3 (Reta) be stored?+ Is GLP-3 (Reta) for human use?+ Stock your lab with Koi Research-grade peptides made in the USA, third-party tested, with public lot-matched COAs
